Keyphrases
Survivors
100%
Cost-effectiveness
100%
Myocardial Infarction
100%
Atorvastatin
100%
Cholesterol Levels
100%
Long-term Benefit
14%
Health-related Quality of Life
14%
Subgroup Analysis
14%
Clinical Health
14%
Markov Model
14%
Cholesterol
14%
Cost-effectiveness Analysis
14%
Quality-adjusted Life Expectancy
14%
Long-term Survival
14%
Coronary Heart Disease Events
14%
Life-years Gained
14%
Incremental Cost
14%
Survival Benefit
14%
Quality-adjusted Life Years
14%
Recurrent Events
14%
Clinical Costs
14%
Life Data
14%
Low-density Lipoprotein Cholesterol Level
14%
Trial Data
14%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Pravastatin
100%
Low Density Lipoprotein Cholesterol
14%
Life Expectancy
14%
Long Term Survival
14%
Ischemic Heart Disease
14%